Orthocell US expansion supports record revenue - ICYMI

Source Summary

Orthocell Ltd (ASX:OCC, OTC:ORHHF) earlier this week reported record quarterly and full-year revenue as accelerating adoption of its RemplirTM nerve repair device strengthened the company’s commercial growth outlook. Revenue reached A$3.8 million in the June quarter, up 20% from the March...